Ganglioneuroblastoma

• CLINICAL_TRIALS trial_result · 2026-03-30
  Clinical Trial Update: Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma [Phase 1, Phase 2]

  This clinical trial update indicates a Phase 1/2 study of dual-target GD2/B7-H3 CAR-NK cells for pediatric relapsed or refractory neuroblast…

• CLINICAL_TRIALS trial_result · 2024-08-14
  Clinical Trial Update: Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL) [Phase 2]

  A Phase 2 trial evaluating a multi-agent regimen of dinutuximab, GM-CSF, isotretinoin, irinotecan, and temozolomide after intensive therapy …

• CLINICAL_TRIALS trial_result · 2023-10-10
  Clinical Trial Update: Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma [Phase 3]

  Phase 3 clinical trial evaluating induction chemoimmunotherapy in high-risk neuroblastoma; currently recruiting.

• CLINICAL_TRIALS trial_result · 2023-03-14
  Clinical Trial Update: Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma [Phase 2]

  Phase 2 trial evaluating dinutuximab with sargramostim and combination chemotherapy for newly diagnosed high-risk neuroblastoma; results hav…

• CLINICAL_TRIALS trial_result · 2019-11-18
  Clinical Trial Update: Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma [Phase 2]

  A phase 2 trial evaluating irinotecan hydrochloride and temozolomide with temsirolimus or dinutuximab in younger patients with refractory or…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2017-09-28
  Clinical Trial Update: Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin [Phase 1]

  Phase 1 trial assessing induction therapy with 131I-MIBG plus chemotherapy for newly diagnosed high-risk neuroblastoma patients undergoing s…

• CLINICAL_TRIALS trial_result · 2017-02-09
  Clinical Trial Update: Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma [Phase 1]

  Phase 1 study assessing consolidation with busulfan and melphalan plus autologous stem cell transplant after chemotherapy in newly diagnosed…